GB1445802A - Pharmaceutical compositions - Google Patents
Pharmaceutical compositionsInfo
- Publication number
- GB1445802A GB1445802A GB1170374A GB1170374A GB1445802A GB 1445802 A GB1445802 A GB 1445802A GB 1170374 A GB1170374 A GB 1170374A GB 1170374 A GB1170374 A GB 1170374A GB 1445802 A GB1445802 A GB 1445802A
- Authority
- GB
- United Kingdom
- Prior art keywords
- immunoglobulins
- animal
- human
- solution
- ethanolamine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 108060003951 Immunoglobulin Proteins 0.000 abstract 6
- 102000018358 immunoglobulin Human genes 0.000 abstract 6
- 229940072221 immunoglobulins Drugs 0.000 abstract 6
- 241001465754 Metazoa Species 0.000 abstract 5
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 abstract 4
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 abstract 2
- 210000002966 serum Anatomy 0.000 abstract 2
- DLWOTOMWYCRPLK-UVTDQMKNSA-N (4z)-5-amino-6-(7-amino-6-methoxy-5,8-dioxoquinolin-2-yl)-4-(4,5-dimethoxy-6-oxocyclohexa-2,4-dien-1-ylidene)-3-methyl-1h-pyridine-2-carboxylic acid Chemical compound C1=CC(OC)=C(OC)C(=O)\C1=C\1C(N)=C(C=2N=C3C(=O)C(N)=C(OC)C(=O)C3=CC=2)NC(C(O)=O)=C/1C DLWOTOMWYCRPLK-UVTDQMKNSA-N 0.000 abstract 1
- 206010061217 Infestation Diseases 0.000 abstract 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 abstract 1
- 229930003427 Vitamin E Natural products 0.000 abstract 1
- 239000002671 adjuvant Substances 0.000 abstract 1
- 230000000202 analgesic effect Effects 0.000 abstract 1
- 230000003110 anti-inflammatory effect Effects 0.000 abstract 1
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 230000003115 biocidal effect Effects 0.000 abstract 1
- 230000000740 bleeding effect Effects 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 abstract 1
- 239000008280 blood Substances 0.000 abstract 1
- 230000001461 cytolytic effect Effects 0.000 abstract 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 abstract 1
- 230000001900 immune effect Effects 0.000 abstract 1
- 230000036039 immunity Effects 0.000 abstract 1
- 238000009169 immunotherapy Methods 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 229940102223 injectable solution Drugs 0.000 abstract 1
- 230000003211 malignant effect Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 230000003071 parasitic effect Effects 0.000 abstract 1
- 230000010412 perfusion Effects 0.000 abstract 1
- 229950006216 rufocromomycin Drugs 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
- 238000002255 vaccination Methods 0.000 abstract 1
- 229940046009 vitamin E Drugs 0.000 abstract 1
- 235000019165 vitamin E Nutrition 0.000 abstract 1
- 239000011709 vitamin E Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
- A61K39/39558—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against tumor tissues, cells, antigens
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR7311456A FR2222084B1 (enExample) | 1973-03-22 | 1973-03-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1445802A true GB1445802A (en) | 1976-08-11 |
Family
ID=9117096
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB1170374A Expired GB1445802A (en) | 1973-03-22 | 1974-03-15 | Pharmaceutical compositions |
Country Status (6)
| Country | Link |
|---|---|
| JP (1) | JPS49125518A (enExample) |
| BE (1) | BE812669A (enExample) |
| DE (1) | DE2413641A1 (enExample) |
| FR (1) | FR2222084B1 (enExample) |
| GB (1) | GB1445802A (enExample) |
| NL (1) | NL7403912A (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS548714A (en) * | 1977-06-16 | 1979-01-23 | Saikin Kagaku Kenkiyuushiyo Kk | Production of specific antiserum |
| DE2949031A1 (de) * | 1978-12-15 | 1980-07-17 | Sandoz Ag | Vakzine |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1247886A (en) * | 1967-10-10 | 1971-09-29 | Sanofi Sa | Therapeutic immunoglobulins and process for their production |
| GB1355962A (en) * | 1970-02-27 | 1974-06-12 | Wellcome Found | Preparation of immunosuppressive materials |
| ES388539A1 (es) * | 1970-02-27 | 1974-02-01 | Wellcome Found | Un metodo de preparacion de un suero antilinfocitivo inmunosupresivo no toxico. |
| BE786564A (fr) * | 1971-07-23 | 1973-01-22 | Upjohn Co | Procede de purification des gamma globulines |
-
1973
- 1973-03-22 FR FR7311456A patent/FR2222084B1/fr not_active Expired
-
1974
- 1974-03-15 GB GB1170374A patent/GB1445802A/en not_active Expired
- 1974-03-21 DE DE19742413641 patent/DE2413641A1/de not_active Withdrawn
- 1974-03-22 BE BE2053498A patent/BE812669A/xx not_active IP Right Cessation
- 1974-03-22 JP JP49032450A patent/JPS49125518A/ja active Pending
- 1974-03-22 NL NL7403912A patent/NL7403912A/xx active Search and Examination
Also Published As
| Publication number | Publication date |
|---|---|
| NL7403912A (enExample) | 1974-09-24 |
| DE2413641A1 (de) | 1974-10-03 |
| JPS49125518A (enExample) | 1974-12-02 |
| FR2222084B1 (enExample) | 1976-05-14 |
| FR2222084A1 (enExample) | 1974-10-18 |
| BE812669A (fr) | 1974-09-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB1508050A (en) | Bovine milk products | |
| JPS63501570A (ja) | 免疫治療方法 | |
| Kitao et al. | Immunostimulation of antibody‐producing cells and humoral antibody to fish bacterins by a biological response modifier | |
| GB1185225A (en) | Injectable Adjuvant, method of preparing same and Compositions including such Adjuvant | |
| Freeman et al. | Activity of metronidazole against experimental tetanus and gas gangrene | |
| Evans | Phagocytosis of murine lymphoma cells by macrophages: I. Factors affecting in vitro phagocytosis | |
| US4374827A (en) | Water soluble extract from nonpathogenic aerobic corynebacteria | |
| SE9704737D0 (sv) | Immunoglobulin-rich milk, production and use thereof | |
| GB1351006A (en) | Water-soluble konjac mannan and a process for the preparation thereof | |
| Ben‐David et al. | HL‐A antigen changes in patients treated with chloramphenicol | |
| Olitzki et al. | Immunological studies on bovine leptospirosis | |
| GB1361886A (en) | N-formyl-dl-homocysteine thiolactone and its use as a drug | |
| RU2101030C1 (ru) | Способ получения антибруцеллезной сыворотки | |
| Spiera et al. | Some factors influencing urinary excretion of 3-hydroxyanthranilic acid | |
| GB1360032A (en) | 2-thio-5-azocytosine and its nucleosides | |
| Stainer et al. | Isomerization of 11-cis vitamin A in vivo | |
| Yamada et al. | The correlation between plasma cell tumor development and antibody response in inbred strains of mice | |
| Mason | The toxin of Clostridium chauvoei | |
| SU122251A1 (ru) | Способ изготовлени ассоциированной концентрат-вакцины против эмфизематозного карбункула, злокачественного отека и пастереллеза крупного рогатого скота | |
| GR33713B (el) | Βελτιωσεις εις τας μεθοδους παραγωγης θεραπευτικων ορων. | |
| US3523155A (en) | Processes for preparation of therapeutic serums | |
| SU135595A1 (ru) | Способ изготовлени вакцины против пастереллеза (холеры) птиц | |
| GB507376A (en) | Process of preparing an antipoliomyelitis serum and the product thereof | |
| Wise et al. | Phenomenon of local skin-reactivity (Shwartzman) to organisms of the brucella group | |
| GOLDBLATT | Severe reaction to griseofulvin: sensitivity investigation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PS | Patent sealed | ||
| PCNP | Patent ceased through non-payment of renewal fee |